Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wexler

Showing results (361-370 of 418) with videos related to

Pageof 42
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 24, 2018
Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitorsCarol H Hu, Tammy C Wang, Jennifer X Qiao, et al.
Journal of Medicinal Chemistry|July 26, 2016
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor ComplexXiaojun Zhang, Peter W Glunz, James A Johnson, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Potent Triazolopyridine Myeloperoxidase InhibitorsNicholas R Wurtz, Andrew Viet, Scott A Shaw, et al.
Journal of Medicinal Chemistry|February 15, 2001
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor XaD J Pinto, M J Orwat, S Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa InhibitorsXiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2014
Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitorsYufeng Wang, Wu Yang, Heather J Finlay, et al.
Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitorsRobert J Cherney, James J-W Duan, Matthew E Voss, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' MoietyZilun Hu, Pancras C Wong, Paul J Gilligan, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2006
Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moietiesDonald J P Pinto, Robert A Galemmo, Mimi L Quan, et al.
Bioorganic & Medicinal Chemistry|April 14, 2016
Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime groupJames R Corte, Tianan Fang, Donald J P Pinto, et al.
Pageof 42

Showing results (361-370 of 418) with videos related to

Sort By:
Pageof 42
Bioorganic & Medicinal Chemistry Letters|October 24, 2018
Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitorsCarol H Hu, Tammy C Wang, Jennifer X Qiao, et al.
Journal of Medicinal Chemistry|July 26, 2016
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor ComplexXiaojun Zhang, Peter W Glunz, James A Johnson, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Potent Triazolopyridine Myeloperoxidase InhibitorsNicholas R Wurtz, Andrew Viet, Scott A Shaw, et al.
Journal of Medicinal Chemistry|February 15, 2001
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor XaD J Pinto, M J Orwat, S Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa InhibitorsXiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2014
Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitorsYufeng Wang, Wu Yang, Heather J Finlay, et al.
Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitorsRobert J Cherney, James J-W Duan, Matthew E Voss, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' MoietyZilun Hu, Pancras C Wong, Paul J Gilligan, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2006
Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moietiesDonald J P Pinto, Robert A Galemmo, Mimi L Quan, et al.
Bioorganic & Medicinal Chemistry|April 14, 2016
Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime groupJames R Corte, Tianan Fang, Donald J P Pinto, et al.
Pageof 42